Skip to main content
Scroll Top
GET OUR EMAIL UPDATES
FOLLOW ON FACEBOOK
CONTACT US
DONATE NOW
Primary Menu
Close
Living With ACC
Living With ACC
Understanding ACC
Stages of Disease
Newly Diagnosed
Monitoring
Advanced Disease
Find a Physician
Peer Support
Patient Champions
Take Action
Patient Events
Donate
Fundraising
Tumor Donations
Treatments
Options
Understanding Treatment Options
Surgery
Radiation
Systemic Therapy
Clinical Trials
Open Studies
Completed Studies
Tumor Profiling
Second Opinions
Video FAQ
Research
Research Landscape
Molecular Targets
Grants
Funded Grants
Kara Gelb Memorial Grant
Grant Opportunities
Published Articles
Research Champions
Tools for Researchers
Research Toolkit
2-D Cell Cultures
PDX Models & Screening Program
GEMMs
Antibodies
Bioinformatics
About Us
Founder’s Story
Leadership
Mission and Strategy
Email Updates Archive
Patient Webinar Archive
Donate
Nivolumab and Ipilumumab (2023)
Home
Clinical Trial
Nivolumab and Ipilumumab (2023)
